AP
EGRX

AHL Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

AHL Partners’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,316
Closed -$472K – 844
2015
Q4 		$472K Buy
+5,316
New +$472K 0.04% 484